Spondyloepimetaphyseal dysplasia, sponastrime type
|
0.320 |
GermlineCausalMutation
|
disease |
ORPHANET |
Overall, these findings indicate that genetic variants resulting in reduced function of TONSL cause SPONASTRIME dysplasia and highlight the importance of TONSL in embryonic development and postnatal growth.
|
30773278 |
2019 |
Spondyloepimetaphyseal dysplasia, sponastrime type
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
Overall, these findings indicate that genetic variants resulting in reduced function of TONSL cause SPONASTRIME dysplasia and highlight the importance of TONSL in embryonic development and postnatal growth.
|
30773278 |
2019 |
Spondyloepimetaphyseal dysplasia, sponastrime type
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
Here, we identified bi-allelic variants in TONSL, which encodes the Tonsoku-like DNA repair protein, in nine subjects (from eight families) with SPONASTRIME dysplasia, and four subjects (from three families) with short stature of varied severity and spondylometaphyseal dysplasia with or without immunologic and hematologic abnormalities, but no definitive metaphyseal striations at diagnosis.
|
30773277 |
2019 |
Spondyloepimetaphyseal dysplasia, sponastrime type
|
0.320 |
GermlineCausalMutation
|
disease |
ORPHANET |
Here, we identified bi-allelic variants in TONSL, which encodes the Tonsoku-like DNA repair protein, in nine subjects (from eight families) with SPONASTRIME dysplasia, and four subjects (from three families) with short stature of varied severity and spondylometaphyseal dysplasia with or without immunologic and hematologic abnormalities, but no definitive metaphyseal striations at diagnosis.
|
30773277 |
2019 |
Liver carcinoma
|
0.310 |
AlteredExpression
|
disease |
BEFREE |
TONSL was predictively targeted by miR-133b, which was downregulated in HCC and negatively related to TONSL mRNA expression (all P < 0.05).
|
30723051 |
2019 |
Liver carcinoma
|
0.310 |
Biomarker
|
disease |
CTD_human |
Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.
|
28284560 |
2017 |
Polycystic Ovary Syndrome
|
0.300 |
Biomarker
|
disease |
CTD_human |
Progesterone resistance in PCOS endometrium: a microarray analysis in clomiphene citrate-treated and artificial menstrual cycles.
|
21411543 |
2011 |
Sclerocystic Ovaries
|
0.300 |
Biomarker
|
disease |
CTD_human |
Progesterone resistance in PCOS endometrium: a microarray analysis in clomiphene citrate-treated and artificial menstrual cycles.
|
21411543 |
2011 |
Orbital separation excessive
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Kyphosis deformity of spine
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Muscle hypotonia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Osteopenia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Osteoporosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Scoliosis, unspecified
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cataract
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Frontal bossing
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Subglottic stenosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hip joint varus deformity - observation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Bulbous nose
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of the dentition
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Congenital kyphoscoliosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Class III malocclusion
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Spondyloepimetaphyseal disorder
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Delayed bone age
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Genu varum
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|